Investing Center Preview – Manage your investments and watch your net worth grow.
GKOS:NYSE – Small Cap Stock (Medical Devices)
Glaukos Corp – GKOS Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
82.61 | 0.34 (+0.41%) | 77.91 - 163.71 | 274.5 thousand (Below Avg) |
Market data as of 11:06AM 04/09/25. Quotes are delayed by at least 15 min.
Overview - GKOS
Open | 81.15 |
---|---|
Previous Close | 82.27 |
Day's Range | 80.50 - 83.36 |
Market Cap | 4.7B |
Avg Volume (10 Day) | 1.2M |
Price/Earnings (Trailing 12 Mo.) | -- |
Earnings Per Share (Trailing 12 Mo.) | -0.871 |
Dividend Yield | No Dividend |
One-Click Scorecard - GKOS


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Fail |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Fail |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Fail |
Stock is undervalued? | Fail |
Have investors caught on? | Fail |
Has support of institutional investors? | Pass |
Has sufficient liquidity? | Pass |
Latest Headlines - GKOS
Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30
Business Wire - Wednesday 04/09/2025 7:00 AM ET
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution
Business Wire - Tuesday 03/11/2025 7:00 AM ET
Industry Position - GKOS
GKOS | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 21.85% | |
Net Income Growth (1yr) | -- | |
Total Debt/Equity | 0.13 | |
LT Debt/Equity | 0.13 | |
Earnings Yield | -- | |
Price/Sales | 11.84 |